> 260 papers in the fields of Gastroenterology and Hepatology, Immunology, Virology, Cardiology, Angiology, Nuclear Medicine, Oncology, Nephrology, Rheumatology, Endocrinology. Numerous Abstracts, prices and lectures at national and international congresses.




Ch.Müller, G.Baumgart:

Beleidigte Leber – Hepatitis, Zirrhose, Leberkarzinom und Co.

Eine Orientierungshilfe für Patienten und Laien

ISBN 978-3-902552-11-2

2007, Verlagshaus der Ärzte, Wien



Selected Scientific Papers

Hucke, F., Sieghart, W., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., Peck-Radosavljevic, M.:

The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE

Journal of Hepatology 2014;60: 118 – 126

Sieghart W. Pinter M. Hucke F. Graziadei I. Schoniger-Hekele M. Muller C. Vogel W. Trauner M. Peck-Radosavljevic M.

Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.

Hepatology. 57(6):2224-34, 2013 Jun.

Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck-Radosavljevic M.

The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.

HEPATOLOGY 2013;57:2261-2273

Wenjun Li, Florence Fenollar, Jean-Marc Rolain,Pierre-Edouard Fournier, Gerhard E. Feurle, Christian Müller,Verena Moos, Thomas Marth, Martin Altwegg,Romana C. Calligaris-Maibach, Thomas Schneider, Federico Biagi, Bernard La Scola and Didier Raoult

Genotyping reveals a wide heterogeneity of Tropheryma whipplei.

Microbiology 2008; 154: 521–527      

F. Biagi, C. Badulli, G. E Feurle, Ch. Müller, V. Moos, Th. Schneider, Th. Marth, J. Mytilineos, F. Garlaschelli, A. Marchese, L.Trotta, P. I. Bianchi, M. Di Stefano, A. L. Cremaschi, A. De Silvestri, L. Salvaneschi, M. Martinetti, G. R Corazza.

Cytokine genetic profile in Whipple’s disease.

European Journal of Clinical Microbiology & Infectious Diseases 2012; 31:3145-3150

M. Pinter, F. Hucke, I. Graziadei, W. Vogel, A. Maieron, R. Königsberg, R. Stauber,  B. Grünberger, Ch. Müller, C. Kölblinger, M. Peck-Radosavljevic, W. Sieghart

Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib.

Radiology 2012; 263:590-99

W. Sieghart, M. Pinter, M. Reisegger, Ch.Müller, A. Ba-Ssalamah, J.Lammer, M.Peck-Radosavljevic

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study.

European Radiology 2012; 22: 1214-1223

M. Pinter, W. Sieghart, F. Hucke, I. Graziadei, W. Vogel, A. Maieron, R. Königsberg, A. Weissmann, G. Kornek, J. Matejka, R. Stauber, R. Buder, B. Grünberger, M. Schöniger-Hekele, C. Müller, M. Peck-Radosavljevic

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Aliment Pharmacol Ther. 2011;34(8):949-59

J. Lammer,K Malagari,T.Vogl, F. Pilleul, A. Denys, A. Watkinson, M. Pitton, G. Sergent, T.Pfammatter, S.Terraz, Y. Benhamou, Y. Avajon, T. Gruenberger, M. Pomoni, H. Langenberger, M. Schuchmann, J. Dumortier, Ch. Mueller, P.Chevallier, R. Lencioni, On Behalf of the PRECISION V Investigators.

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma:

Results of the PRECISION V Study

Cardiovasc Intervent Radiol (2010) 33:41–52

Dolak, W. Leitner, J. Maresch, J. Wrba, F. Mueller, C.

In vivo identification by confocal laser endoscopy of foamy macrophages associated with Whipple's disease.

Endoscopy. 2010;42: Suppl 2:E310-1

M.Schöniger-Hekele, J.Kettenbach, M.Peck-Radosavljevic, Ch.Müller:

Octreotide treatment of patients with hepatocellular carcinoma – a retrospective single center controlled study.

J.Exp.and Clin.Cancer Research 2009; 28: 142

M.Martinetti, F.Biagi, C.Badulli, G.E.Feurle, Ch.Müller, V.Moos, Th.Schneider, Th.Marth, A.Marchese, L.Trotta, S.Sachetto, A.Pasi, A.De Silvestri, L.Salvaneschi, G.R.Corazza:

The HLA Alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease.

Gastroenterology 2009; 136:2289-2294

Ch.Müller, M.Schöniger-Hekele, R.Schernthaner, B.Renner, M.Peck-Radosavljevic, A.Brichta, M.Posch, P.Bauer, P.Ferenci, A.Gangl

Percutaneous ethanol instillation therapy for hepatocellular carcinoma – a randomized controlled trial.

Wien Klin Wochenschr 2008; 120: 608-618

Pinter M., Wichlas M., Schmid K., Plank Ch., Müller Ch., Wrba F., Peck-Radosavljevic M.

Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial.

Eur J Gastroenterol Hepatol 2008; 20: 1012-1019

M. Blum, Ch.Müller, M.Peck-Radosavljevic, Wrba F., Berlakovich G., Mühlbacher F., Steininger R., Speiser M., Pones M., Hüpfl M., Lammer J., Kettenbach J.

MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplanation.

Minimally invasive therapy 2007; 4: 230-240.

L.Jessner, T.Watkins-Riedel, Ch.Müller, E.Formann, M.Gschwantler, P.Ferenci:

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV monitor, version 2.0, assays in HCV genotype 4 infection.

J.of Viral Virology 2007

L. Dzirlo, M.Hubner, Ch. Müller, B. Blaha, E. Formann, Ch. Dellinger, P. Petzelbauer, L. Müllauer, K. Huber, M. Kneussl, M. Gschwantler

Sarcoidosis-like lesions of the lung and the skin

Lancet 2007; 369: 1832

M.Schöniger-Hekele, Ch.Müller, L.Kramer, E.Dauber, W.R.Mayr, F.Wrba, S.Rockenschaub, F.Mühlbacher:

Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms

Digestion 2006; 74: 169-173

M.Schöniger-Hekele, D.Petermann, B.Weber, Ch.Müller:

Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers.

Applied and Environmental Microbiology 2007; 73

V.Fuhrmann, Ch.Madl, Ch.Müller, U.Holzinger, R.Kitzberger, G-Ch.Funk, P.Schenk:

Hepatopulmonary syndrome in patients with hypoxic hepatitis.

Gastroenterology 2006; 131: 69-75.

M. Schöniger-Hekele, S.Hänel, F.Wrba, Ch.Müller:

Hepatocellular carcinoma – survival and clinical characteristics in relation to various histologic molecular markers in Western patients.

Liver Int 2005; 25: 62-69

M. Schöniger-Hekele, Ch.Müller:

The combined elevation of tumor markers CA 19.9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis.

Dig.Dis.Sci. 2006; 51: 338-345

T.Watkins-Riedel, P.Ferenci, P.Steindl-Munda, M.Gschwantler, Ch.Müller, M.Wögerbauer:

Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCVRNA whole-blood analysis.

Clinical Infectious Diseases 2004; 39: 1754-1760

P.Schenk, M.Schöniger-Hekele, V.Fuhrmann, Ch.Madl, G Silberhumer, Ch.Müller:

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Gastroenterology 2003; 125: 1042-1052